What’s the latest on sulphonylureas in the management of type 2 diabetes?
Sulphonylureas act by binding to sulphonylurea receptors and stimulating insulin secretion from pancreatic beta cells. This class of oral hypoglycaemic agents is still widely used in the management of type 2 diabetes in patients where lifestyle changes alone are insufficient. Although the older-gene...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AOSIS
2013-12-01
|
| Serie: | South African Family Practice |
| Soggetti: | |
| Accesso online: | https://safpj.co.za/index.php/safpj/article/view/3945 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|